Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE1633.4063.95 (+4.07 %)

PREV CLOSE ( ) 1569.45

OPEN PRICE ( ) 1621.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3323

TODAY'S LOW / HIGH ( )1593.65 1664.90

52 WK LOW / HIGH ( )945 1727

NSE1633.2049.15 (+3.1 %)

PREV CLOSE( ) 1584.05

OPEN PRICE ( ) 1597.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 89537

TODAY'S LOW / HIGH( ) 1589.00 1665.90

52 WK LOW / HIGH ( )945 1729

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-03 1995

Management Info

Devendra Mehta - Chairman Himanshu Baid - Managing Director

Registered Office

Address 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I I,
New Delhi,
Delhi-110020

Phone 011 - 33550700 / 47317000

Email info@polymedicure.com

Website www.polymedicure.com

Registrars Details

MAS Services Ltd

T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi

Listing : BSE, NSE, MCX

NEWS

04Mar Allotment of Equity Shares
Inter alia, to consider the following:- a) Business Plan for Financial..

17Jan Poly Medicure informs about board meet
Poly Medicure has informed that a meeting of the Board of Directors of t..

30Apr Poly Medicure informs about disclosure
Poly Medicure has informed that the exchange has received the disclosure..

11Feb Poly Medicure informs about analyst meet
Poly Medicure has informed that an earnings call will be held on friday,..

29Jul Poly Medicure informs about earnings c
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	614.6	1790.44
Gross Profit	820.89	2368.26
Operating Profit	1009.64	3007.64
Net Sales	3208.64	10680.45

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Shree Pacetronix (BSE) 243.60 (5.00%)	M.Cap ( in Cr)87.68
Hemant Surgical Inds (BSE) 142.00 (1.03%)	M.Cap ( in Cr)148.25
Kretto Syscon (BSE) 0.80 (2.56%)	M.Cap ( in Cr)12.54
Centenial Surgical (BSE) 101.99 (-0.01%)	M.Cap ( in Cr)37.21
GKB Ophthalmics (BSE) 113.67 (-0.56%)	M.Cap ( in Cr)57.30

Shareholding Pattern

	PROMOTERS	53.15%
	NON-INSTITUTION	27.26%
	MUTUAL FUNDS/UTI	4.99%
	FI/BANKS/INSURANCE	2.01%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bank of India Small...	1.63
Quant Small Cap Fund(G)	1.55
UTI Flexi Cap Fund-...	1.25
UTI Healthcare Fund...	1.05
HSBC Tax Saver Equi...	1.00
Motilal Oswal S&P B...	0.72
WOC Flexi Cap Fund-Reg(G)	0.69

Risk Disclosures on Derivatives

Smart Quotes

POLY MEDICURE LTD.